| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| DLEU1 |
O43261
|
deleted in lymphocytic leukemia 1
|
|
0.47 |
0.569 |
0.692 |
| JMJD1C |
Q15652
|
jumonji domain containing 1C
|
|
1.00 |
0.517 |
0.769 |
| CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
| FOXP1 |
Q9H334
|
forkhead box P1
|
|
1.00 |
0.460 |
0.808 |
| CDKAL1 |
Q5VV42
|
CDK5 regulatory subunit associated protein 1 like 1
|
|
1.6E-02 |
0.617 |
0.615 |
| HFE |
Q30201
|
homeostatic iron regulator
|
|
2.6E-08 |
0.436 |
0.846 |
| MAPT |
P10636
|
microtubule associated protein tau
|
|
6.0E-03 |
0.446 |
0.923 |
| RERE |
Q9P2R6
|
arginine-glutamic acid dipeptide repeats
|
|
1.00 |
0.526 |
0.846 |
| CADM2 |
Q8N3J6
|
cell adhesion molecule 2
|
|
0.89 |
0.670 |
0.538 |
| TET2 |
Q6N021
|
tet methylcytosine dioxygenase 2
|
|
4.3E-54 |
0.458 |
0.808 |
| KANSL1 |
Q7Z3B3
|
KAT8 regulatory NSL complex subunit 1
|
|
1.00 |
0.592 |
0.731 |
| MAD1L1 |
Q9Y6D9
|
mitotic arrest deficient 1 like 1
|
|
6.8E-16 |
0.570 |
0.731 |
| LINC01122 |
|
long intergenic non-protein coding RNA 1122
|
|
|
0.821 |
0.269 |
| BANK1 |
Q8NDB2
|
B cell scaffold protein with ankyrin repeats 1
|
|
4.8E-12 |
0.653 |
0.538 |
| C2 |
P06681
|
complement C2
|
|
1.3E-16 |
0.617 |
0.692 |
| MAPT-AS1 |
|
MAPT antisense RNA 1
|
|
|
0.711 |
0.269 |
| CCDC162P |
|
coiled-coil domain containing 162, pseudogene
|
|
|
0.890 |
0.154 |
| ZNF365 |
Q70YC4 Q70YC5
|
zinc finger protein 365
|
|
4.7E-04 |
0.641 |
0.654 |
| LRP1B |
Q9NZR2
|
LDL receptor related protein 1B
|
|
2.5E-06 |
0.626 |
0.615 |
| LINC02210-CRHR1 |
P34998
|
LINC02210-CRHR1 readthrough
|
|
|
0.570 |
0.692 |
| AUTS2 |
Q8WXX7
|
activator of transcription and developmental regulator AUTS2
|
|
1.00 |
0.569 |
0.846 |
| LINC00461 |
|
long intergenic non-protein coding RNA 461
|
|
|
0.736 |
0.423 |